About this trial
This study is being completed to test a method to promote patient-centered outcomes among people who use cannabis behaviors.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
current cannabis use disorder
active cannabis use,
camera/technology/phone access
able to give informed consent.
Disqualifiers
inability to speak English
conditions precluding informed consent, full participation, or understanding of interventions/assessments
past 90-day cannabis use disorder/substance use disorder treatment
current cancer treatment
Trial design
Parallel
Treatments tested in this trial
Motivational and Behavioral Economics Informed Intervention
Behavioral6 session telemedicine-delivered intervention with coaching sessions and small incentives for activity engagement.
Enhanced Usual Care
BehavioralBrief psychoeducation and referral resources
Treatment groups
Trial outcomes
Primary outcomes
Cannabis use
Change in frequency of cannabis use measured by the Timeline Follow Back
Secondary outcomes
Cannabis use disorder symptoms
Change in cannabis use disorder symptoms measured by the Diagnostic \& Statistical Manual-5 checklist where higher scores indicate a worse outcome (0 min score, 11 max score)
Depressive symptoms
Change in depression symptom severity as measured by Patient Health Questionnaire-where higher scores indicate a worse outcome (min score = 0, max score = 24)
Anxiety symptoms
Change in anxiety symptom severity as measured by Generalized Anxiety Disorder-7 questionnaire where higher scores indicate a worse outcome (min score = 0, max score = 21)
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
University of Michigan
Lead sponsor
National Institute on Drug Abuse (NIDA)
Collaborator
This trial is not recruiting at the moment. You can still explore other options: